InvestorsHub on MSN
Roche receives FDA clearance for cobas BV/CV assay, expanding women’s health diagnostics
The new molecular test broadens Roche’s sexual-health diagnostics portfolio by enabling simultaneous detection of bacterial ...
The global food safety testing market is projected to grow from $28.1 billion in 2026 to $52.9 billion by 2034, driving ...
Seegene USA's Allplex HSV-1&2/VZV/MPXV Assay receives Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) The multiplex real-time PCR assay ...
Seegene, a global molecular diagnostics company, announced Tuesday that its US subsidiary Seegene USA has received emergency ...
EUA marks the first U.S. multiplex PCR capable of differential detection of HSV-1, HSV-2, VZV, and MPXV from a single specimen. Overlapping lesion morphology makes sequential single-pathogen testing ...
Virus-only testing may miss pneumonia-associated bacterial co-detections in 78% of virus-positive cases, while bacteria-only testing may miss viral co-detections in 88% of cases positive for pneumonia ...
In less than four minutes, an automatic system detected a fire in a moving car inside the Dwarka Expressway tunnel, activated ...
Key opportunities in the dye-free and label-free PCR packaging market include surging demand for precision genomic testing, ...
Nifty 50 (24,207) slipped 0.3 per cent over the past week, whereas Nifty Bank (58,046) edged up 0.2 per cent. The muted performance reflects a loss of momentum after the recovery ...
The hepatitis testing market presents significant opportunities driven by rising hepatitis infections, increasing demand for early diagnosis, and advancements in rapid point-of-care testing. Key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results